Quantcast

The Chris Elliott Fund Announces the New Brains Matter Webinar Series on Brain Tumor and Brain Cancer Treatment and Care

January 14, 2013

The Chris Elliott Fund’s monthly Brains Matter Webinar Series will be sharing the latest advancements in brain tumor treatments while also connecting patients and caregivers with national specialists. This webinar series is part of the Chris Elliott Fund’s plan grow our team of rockstar healthcare advocates.

Seattle, Wash. (PRWEB) January 14, 2013

The Chris Elliott Fund (CEF) is pleased to announce the first of several webinars that will be offered monthly, and free of charge, by the Seattle based brain cancer and brain tumor patient advocacy & services group. The first webinar, titled “10 vital questions you must ask your doctor IMMEDIATELY when diagnosed with a brain tumor,” focuses on how to become a rockstar and advocate for your own healthcare. This webinar will feature Dr. Greg Foltz, Neurosurgeon and Director of the Ivy Brain Tumor Center at Swedish Neuroscience Institute in Seattle, Washington.

The webinar will also include conversations with Dellann Elliott, President & Founder of the Chris Elliott Fund as well as Maria Barrett, Health Information Concierge at the Chris Elliott Fund. This webinar is a unique opportunity for national brain cancer/brain tumor patients and caregivers to engage with experts in the field, who are tapped into the current news and treatment options for brain tumors.

Maria Barrett, coordinator for the webinar series and Health Information Concierge at CEF says “the rush to learn as much vitally important information about your brain tumor, once diagnosed, is easily overwhelming. We´d like to help simplify this process by sharing the 10 most important questions to ask your neurosurgeon or neuro-oncologist.”

This first of the CEF webinars, “10 Vital questions you must ask your doctor IMMEDIATELY when diagnosed with a brain tumor,” will touch on important things new brain tumor patients should know about brain cancer treatment and help them guide the conversation with their doctor to make sure they have the right information before executing their treatment plan.

Register online today: http://bit.ly/BrainsMatterWeb1

The Chris Elliott Fund is able to offer these vital services to brain tumor patients and caregivers through the generous support from Genentech, a biotechnology company based in San Francisco, and member of the Roche Group.

About the Chris Elliott Fund:

The Chris Elliott Fund (CEF) is a patient advocacy organization and national 501(c)(3) non-profit with corporate offices in Seattle, Washington, with goals to end brain cancer through education, advocacy, awareness and support. Established in 2002, CEF has grown to provide support nationally for brain cancer and brain tumor patients seeking guidance, advice, and assistance to demystify finding the absolute best course of treatment for their brain cancer or brain tumor. This has been made possible over the past 11 years through the Chris Elliott Fund´s world class call center, through raising more than $1.5 million for research advocacy and support, in establishing the Christopher Stewart Elliott Neuro-Oncology Lab for Glioblastoma at the Dana-Farber Cancer Institute in Boston, in establishing the Integrated Patient Support Program at the Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment in Seattle’s Swedish Neuroscience Institute and being a leader in funding key scientific research to end the disease. The organization and its advocates, on average, serve 500-800 patients and caregivers per month, free of charge. If we can help, please contact us at WeCare(at)EndBrainCancer(dot)com

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10310052.htm


Source: prweb



comments powered by Disqus